Biotech

All Articles

Biogen, UCB file period 3 lupus gain after stopping working earlier test

.Biogen and also UCB's depend developing right into phase 3 astride a broken study wants to have pai...

Aptadir hopes brand-new RNA inhibitors may reverse challenging cancers cells

.Italian biotech Aptadir Therapies has actually launched with the promise that its pipeline of precl...

Wave surfs DMD results to regulatory authorities' doors, sending out stockpile

.Wave Lifestyle Sciences has actually satisfied its objective in a Duchenne muscular dystrophy (DMD)...

Sanofi tweezes brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma crease, using up the...

Achilles trickles tissue treatment program, bandages for discharges after overlooking 'commercial feasibility' targets

.Achilles Rehabs has destroyed its own strategy. The English biotech is quiting working on its own c...

Aligos proclaims phase 2 MASH gain, lowering liver fat approximately 46%

.Aligos Therapeutics is declaring a midstage win in metabolic-dysfunction connected steatohepatitis ...

Basilea credit ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job creating brand-new antifungals has acquired a substantial improvement c...

Capricor sells Europe civil rights to late-stage DMD treatment for $35M

.Having currently scooped up the U.S. civil liberties to Capricor Therapies' late-stage Duchenne mus...

FDA scraps adcomm for Applied's rare disease medication

.After pushing back the selection date for Applied Therapeutics' metabolic condition medicine govore...

Novo inks $600M NanoVation bargain to study genetic drugs ex-liver

.Novo Nordisk is continuing its press into genetic medicines, accepting compensate NanoVation Rehabs...